Dr. Kosaraju is the Vice President for Global Development of SIGA Technologies, a company that specializes in small molecule drugs for emerging disease threats and biological warfare defense. She received her M.D. from Columbia University College of Physicians and Surgeons and her B.A. in Human Biology from Stanford University. Dr. Kosaraju was a White House appointee in the Pentagon, serving as the Special Assistant to the Assistant Secretary of Defense for Health Affairs. In this capacity, she provided executive leadership in the management of a 42 billion-dollar Military Health System that included healthcare for military service members, bio-defense, and international humanitarian assistance. She received the Office of the Secretary of Defense Medal for Exceptional Public Service, the highest non-career civilian honor given within the Department of Defense. She is a term member of the Council on Foreign Relations, is a member of the International Institute for Strategic Studies, the Boards of the Alliance for Biosecurity and the International Security and Biopolicy Institute, and serves on the Materials Technical Advisory committee for the Department of Commerce.
Announcing New Members of Concordia’s Advisory Board
Concordia is pleased to announce the appointment of a distinguished group of global leaders to its Advisory Board. Representing a diverse range of sectors, geographies, and areas of expertise, these individuals bring
